# A Pre-surgical Study of LDE225 in Men With High-risk Localized Prostate Cancer

> **NCT02111187** · PHASE1 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 14 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** LDE225

## Key facts

- **NCT ID:** NCT02111187
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2017-01-18
- **Final completion:** 2017-01-18
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02111187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02111187, "A Pre-surgical Study of LDE225 in Men With High-risk Localized Prostate Cancer". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02111187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*